Prospective Evaluation of Idiopathic Pancreatitis: Role of Endoscopic Ultrasonography

This study is currently recruiting participants.

Verified December 2011 by University of Alabama at Birmingham

First Received on January 24, 2008. Last Updated on December 5, 2011 History of Changes

Sponsor:	Charles Mel Wilcox, MD
Information provided by (Responsible Party):	Charles Mel Wilcox, MD, University of Alabama at Birmingham
ClinicalTrials.gov Identifier:	NCT00609726

Purpose

The purpose of the study is to determine the best evaluation for patients with idiopathic (unexplained) pancreatitis.

Condition
Gallbladder Disease Pancreatitis

Study Type:	Observational
Study Design:	Observational Model: Case Control Time Perspective: Prospective
Official Title:	Prospective Evaluation of Idiopathic Pancreatitis: Role of Endoscopic Ultrasonography

Resource links provided by NLM:

MedlinePlus related topics: Endoscopy Gallbladder Diseases Pancreatitis Ultrasound

U.S. FDA Resources

Further study details as provided by University of Alabama at Birmingham:

Estimated Enrollment:	200
Study Start Date:	October 2004
Estimated Study Completion Date:	January 2014
Estimated Primary Completion Date:	October 2013 (Final data collection date for primary outcome measure)

Detailed Description:

The study evaluates the role of endoscopic ultrasonography, given that the minimally invasive procedures can diagnosis gallbladder disease as well as pancreatitis abnormalities.

Eligibility

Ages Eligible for Study:	19 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes
Sampling Method:	Non-Probability Sample

Study Population

Men and women diagnosed with unexplained pancreatitis.

Criteria

Inclusion Criteria:

All patients referred to the principal investigator for unexplained pancreatitis will be enrolled.

Exclusion Criteria:

There are no gender nor racial exclusion.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00609726

Contacts

Contact: Charles M Wilcox, M.D.

205-975-4958

Locations

United States, Alabama
University of Alabama	Recruiting
Birmingham, Alabama, United States, 35294

Sponsors and Collaborators

Charles Mel Wilcox, MD

Investigators

Principal Investigator:

Charles M Wilcox, M.D.

University of Alabama at Birmingham

More Information

No publications provided

Responsible Party:	Charles Mel Wilcox, MD, Principal Investigator, University of Alabama at Birmingham
ClinicalTrials.gov Identifier:	NCT00609726 History of Changes
Other Study ID Numbers:	X040909004, 228552
Study First Received:	January 24, 2008
Last Updated:	December 5, 2011
Health Authority:	United States: Institutional Review Board

Keywords provided by University of Alabama at Birmingham:

Endoscopic Ultrasonography
Pancreatitis
EUS

Additional relevant MeSH terms:

Gallbladder Diseases
Pancreatitis
Biliary Tract Diseases
Digestive System Diseases
Pancreatic Diseases

ClinicalTrials.gov processed this record on February 12, 2012